PFC
UTHR icon

Poplar Forest Capital’s United Therapeutics UTHR Stock Holding History

Poplar Forest Capital’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$18.4M Sell
59,833
-42
-0.1% -$14.4K 3.28% 13
2024
Q4 		$21.1M Sell
59,875
-50,244
-46% -$18.5M 3.89% 11
2024
Q3 		$39.5M Sell
110,119
-500
-0.5% -$169K 5.37% 1
2024
Q2 		$35.2M Sell
110,619
-300
-0.3% -$79.4K 4.92% 2
2024
Q1 		$25.5M Sell
110,919
-70
-0.1% -$15.8K 3.42% 15
2023
Q4 		$24.4M Sell
110,989
-59,914
-35% -$13.8M 3.55% 16
2023
Q3 		$38.6M Buy
170,903
+23,093
+16% +$5.32M 4.48% 5
2023
Q2 		$32.6M Sell
147,810
-6,109
-4% -$1.35M 4.27% 7
2023
Q1 		$34.5M Buy
153,919
+4,460
+3% +$1.1M 4.11% 6
2022
Q4 		$41.6M Sell
149,459
-18,600
-11% -$4.7M 5.01% 1
2022
Q3 		$35.2M Buy
168,059
+145
+0.1% +$32.4K 4.49% 4
2022
Q2 		$39.6M Sell
167,914
-564
-0.3% -$115K 4.54% 3
2022
Q1 		$30.2M Buy
168,478
+7,172
+4% +$1.37M 3.15% 15
2021
Q4 		$34.9M Sell
161,306
-11,547
-7% -$2.27M 3.66% 13
2021
Q3 		$31.9M Sell
172,853
-4,288
-2% -$845K 3.28% 16
2021
Q2 		$31.8M Buy
177,141
+175,567
+11,154% +$33.4M 3.12% 20
2021
Q1 		$263K Buy
+1,574
New +$262K 0.03% 76

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Poplar Forest Capital's UTHR Position: Q1 2025 in Review

Poplar Forest Capital reduced its United Therapeutics (UTHR) stake by 0.07% in Q1 2025, selling an estimated $14.4K and leaving 59,833 shares worth $18.4M. The position accounts for 3.28% of the portfolio, ranked #13.

Poplar Forest Capital first reported a position in UTHR in Q1 2021 and has held it in 17 quarters since. The position peaked at $41.6M in Q4 2022. 671 funds tracked by Wall St. Rank hold UTHR as of Q1 2025.

  • Poplar Forest Capital held 59,833 shares of United Therapeutics worth $18.4M as of Q1 2025.
  • Poplar Forest Capital sold 42 United Therapeutics shares in Q1 2025, an estimated $14.4K.
  • United Therapeutics made up 3.28% of Poplar Forest Capital's portfolio in Q1 2025, its #13 holding.
  • Poplar Forest Capital first reported a position in United Therapeutics in Q1 2021 and has held it in 17 quarters since.
  • Poplar Forest Capital's United Therapeutics position peaked at $41.6M in Q4 2022.
  • 671 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2025.

Based on Poplar Forest Capital's 13F filing for Q1 2025, filed 6 May 2025.